B. Riley
http://www.brileyco.comB. Riley provides investment banking services to wide range of companies, as well as research and trading ideas to individual and institutional clients.
View Older Stories View More Recent Stories
-
B. Riley Financial (RILY) Declines 8% Following Report Franchise Group's Brian Kahn Said To Step Down As CEO
-
Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement
-
B. Riley Financial (RILY) call put ratio 1 call to 2.4 puts on option volume of 52K contracts
-
B. Riley Financial (RILY) stock drops 19% on SEC probe report
-
B. Riley Financial Issues Statement
-
SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News
-
AST SpaceMobile (ASTS) Prices 32.26M Share Offering at $3.10/sh
-
AST SpaceMobile, Inc. Announces Pricing of $100,000,000 Public Offering of Class A Common Stock
-
Form 4 TRANSACT TECHNOLOGIES For: Jan 16 Filed by: B. Riley Financial, Inc.
-
AST SpaceMobile (ASTS) Launches $100M Share Offering
-
AST SpaceMobile, Inc. Announces Launch of Offering of $100,000,000 of Class A Common Stock
-
Perspective Therapeutics (CATX) Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
-
Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
-
Hydrogen stock, Plug Power (PLUG), is already down 40% YTD. Analyst explains what's next.
-
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
-
After-hours movers: Discover Financial, Hertz, Plug Power and more
-
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
-
Plug Power (PLUG) sinks on massive ATM agreement
-
Plug Power (PLUG) Files $1B ATM
-
Perspective Therapeutics Announces Proposed Public Offering
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
-
Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference
-
Applied Digital Reports Fiscal Second Quarter 2024 Results
-
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
-
Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference
-
Form 4 TRANSACT TECHNOLOGIES For: Jan 10 Filed by: B. Riley Financial, Inc.
-
Geron to Participate in the B. Riley Securities Virtual Oncology Conference
-
CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference
-
Eagle Point Credit (ECC) Prices Offering of Preferred Shares
-
Eagle Point Credit Company Inc. Prices Offering of Preferred Stock
-
Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference
-
Eagle Point Credit (ECC) Announces Preferred Share Offering
-
Eagle Point Credit Company Inc. Announces Offering of Preferred Stock
-
Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
-
Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference
-
UroGen Pharma to Participate in the B. Riley Healthcare Conference
-
Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference
-
Main Street Capital (MAIN) Prices $350M Notes Offering
-
Main Street Prices Public Offering of $350 Million of 6.95% Notes due 2029
-
Form 4 TRANSACT TECHNOLOGIES For: Jan 05 Filed by: B. Riley Financial, Inc.
-
B. Riley Financial Declares Preferred Stock Dividends
-
Sixth Street Specialty Lending (TSLX) Prices $350M Notes Offering
-
Sixth Street Specialty Lending, Inc. Prices Public Offering of $350.0 million 6.125% Unsecured Notes due 2029
-
Analysis-Unloved healthcare stocks draw investors despite US election risks
-
Immunic Inc. (IMUX) Announces $240M Private Placement
-
Immunic, Inc. Announces Private Placement of up to $240 Million
-
Core Scientific (CORZQ) Announces Full Pay Down of Debtor-in-Possession Financing
-
Core Scientific, Inc. Announces Full Pay Down of Debtor-in-Possession Financing
-
Agenus to Participate in B. Riley Healthcare Conference
-
Via Renewables (VIA) Enters Agreement for Its Class A Common Stock to be Acquired at $11/sh Cash

